ORKA

Oruka Therapeutics, Inc. $96.87 as of 2026-10-30
Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+0.3%
Next 1 week
-0.5%
Next 1 month
+3.5%
Seasonality
Bullish window historically
Next 30 days (to Dec 2): +2.5% median, 61% of the last 28 years finished up.
20-year seasonality chart →
Mean reversion
Deeply overbought — RSI(2) at 98
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is -0.25%/day.
Mean-reversion stats →
1-month breakdown — Market · β 1.43 +3.4% · Seasonal tilt +0.1%
$75M/day volume 69% volatility +251% 1-year
52-week range · 79% of the way up · -16% from the high
$25.23$115.52

Earnings Full history →

Next report 2026-11-11 (Wednesday, before open, in 9 days) · EPS est. -0.62.

1-day std dev
10.2%
Finished up
62%
Biggest pop
+25.0%
Biggest drop
-6.8%

Standard deviation of the close-to-close move over the last 8 reports. History, not a forecast.

ReportedEst.Actual SurpriseGap Day 1Day 5
2026-08-10 miss -0.50 -0.55 -9.9% -2.3% +6.4% +14.0%
2026-05-13 beat -0.54 -0.48 +10.6% +0.3% +1.1% -7.1%
2026-03-12 beat -0.62 -0.45 +26.9% +2.7% +25.0% +21.6%
2025-11-12 miss -0.52 -0.55 -5.0% +5.3% -6.8% -4.6%
2025-08-11 miss -0.43 -0.46 -6.4% +1.3% +6.9% +11.6%
2025-05-14 beat -0.44 -0.40 +9.1% +8.0% -2.6% +15.2%
2025-03-06 miss -0.41 -0.49 -18.6% -0.9% +3.9% +10.1%
2024-11-13 miss -0.32 -1.46 -351.6% -3.0% -6.4% -20.1%

Not investment advice.